• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生成三对年龄和性别匹配的人诱导多能干细胞,分别来源于供者的成肌细胞(MDCi011-A、MDCi012-A、MDCi013-A)和外周血单核细胞(MDCi011-B、MDCi012-B、MDCi013-B)。

Generation of three age and gender matched pairs of human induced pluripotent stem cells derived from myoblasts (MDCi011-A, MDCi012-A, MDCi013-A) and from peripheral blood mononuclear cells (MDCi011-B, MDCi012-B, MDCi013-B) from the same donor.

机构信息

Muscle Research Unit, Experimental and Clinical Research Center, a joint cooperation of Charité, Universitätsmedizin Berlin and the Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany; Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.

Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.

出版信息

Stem Cell Res. 2020 Oct;48:101987. doi: 10.1016/j.scr.2020.101987. Epub 2020 Sep 8.

DOI:10.1016/j.scr.2020.101987
PMID:32961449
Abstract

We describe the generation and characterization of three pairs of human induced pluripotent stem cell (hiPSC) lines reprogrammed from myoblasts and from peripheral blood mononuclear cells (PBMCs) of the same donor. All donors were free of neuromuscular disorders, female and between 47 and 50 years of age. For reprogramming we used Sendai-virus delivery of the four Yamanaka factors. The pluripotent identity of the hiPSC lines was confirmed by the expression of pluripotency markers and their capacity to differentiate into all three germ layers. These hiPSCs constitute a tool to study tissue of origin specific differences in the identity of hiPSCs.

摘要

我们描述了三对人类诱导多能干细胞(hiPSC)系的产生和特征,这些细胞系是由同一供体的成肌细胞和外周血单核细胞(PBMC)重新编程而来。所有供者均无神经肌肉疾病,均为女性,年龄在 47 至 50 岁之间。我们使用 Sendai 病毒传递了四个 Yamanaka 因子进行重编程。hiPSC 系的多能性通过多能性标志物的表达及其分化为三个胚层的能力得到确认。这些 hiPSC 构成了研究 hiPSC 起源组织特异性差异的工具。

相似文献

1
Generation of three age and gender matched pairs of human induced pluripotent stem cells derived from myoblasts (MDCi011-A, MDCi012-A, MDCi013-A) and from peripheral blood mononuclear cells (MDCi011-B, MDCi012-B, MDCi013-B) from the same donor.生成三对年龄和性别匹配的人诱导多能干细胞,分别来源于供者的成肌细胞(MDCi011-A、MDCi012-A、MDCi013-A)和外周血单核细胞(MDCi011-B、MDCi012-B、MDCi013-B)。
Stem Cell Res. 2020 Oct;48:101987. doi: 10.1016/j.scr.2020.101987. Epub 2020 Sep 8.
2
Generation of two human induced pluripotent stem cell lines derived from myoblasts (MDCi014-A) and from peripheral blood mononuclear cells (MDCi014-B) from the same donor.从同一供体的成肌细胞(MDCi014-A)和外周血单个核细胞(MDCi014-B)中产生了两个人诱导多能干细胞系。
Stem Cell Res. 2020 Oct;48:101998. doi: 10.1016/j.scr.2020.101998. Epub 2020 Sep 17.
3
Xeno-Free Reprogramming of Peripheral Blood Mononuclear Erythroblasts on Laminin-521.无血清条件下层粘连蛋白 521 对人外周血单个核细胞红系前体细胞的重编程
Curr Protoc Stem Cell Biol. 2020 Mar;52(1):e103. doi: 10.1002/cpsc.103.
4
Derivation of a human induced pluripotent stem cell (hiPSC) line (PUMCSMi001-A) from peripheral blood mononuclear cells of one healthy female donor.从一位健康女性供体的外周血单个核细胞中诱导产生人诱导多能干细胞(hiPSC)系(PUMCSMi001-A)。
Stem Cell Res. 2021 May;53:102312. doi: 10.1016/j.scr.2021.102312. Epub 2021 Mar 24.
5
Generation of the induced pluripotent stem cell line UHOMi002-A from peripheral blood mononuclear cells of a healthy male donor.从一名健康男性供体的外周血单个核细胞中生成诱导多能干细胞系UHOMi002-A。
Stem Cell Res. 2020 Dec;49:102037. doi: 10.1016/j.scr.2020.102037. Epub 2020 Oct 8.
6
Generation and characterization of the human induced pluripotent stem cell line NMIi010-A from peripheral blood mononuclear cells of a healthy 49-year old male individual.从一名健康 49 岁男性外周血单个核细胞中诱导生成并鉴定人诱导多能干细胞系 NMIi010-A。
Stem Cell Res. 2021 Jul;54:102427. doi: 10.1016/j.scr.2021.102427. Epub 2021 Jun 11.
7
Generation and characterisation of a human induced pluripotent stem cell line, NIMHi007-A, from peripheral blood mononuclear cells derived from an adult healthy female.从一名健康成年女性外周血单个核细胞中诱导生成人多能干细胞系 NIMHi007-A 及其特性鉴定。
Stem Cell Res. 2023 Aug;70:103130. doi: 10.1016/j.scr.2023.103130. Epub 2023 May 27.
8
Establishment of an induced pluripotent stem cell line (ZZUSAHi002-A) derived from peripheral blood mononuclear cells of a healthy individual.建立源自健康个体外周血单个核细胞的诱导多能干细胞系(ZZUSAHi002-A)。
Stem Cell Res. 2020 Oct;48:101966. doi: 10.1016/j.scr.2020.101966. Epub 2020 Aug 27.
9
Generation of four severe early-onset chronic obstructive pulmonary disease (COPD) patient-derived induced pluripotent stem cell lines from peripheral blood mononuclear cells.从外周血单核细胞中生成四条严重早发性慢性阻塞性肺疾病(COPD)患者来源的诱导多能干细胞系。
Stem Cell Res. 2021 Oct;56:102550. doi: 10.1016/j.scr.2021.102550. Epub 2021 Sep 27.
10
Generation of a healthy heavy smoker patient-derived induced pluripotent stem cell line UHOMi007-A from peripheral blood mononuclear cells.从外周血单核细胞中生成健康的重度吸烟患者来源的诱导多能干细胞系 UHOMi007-A。
Stem Cell Res. 2024 Jun;77:103437. doi: 10.1016/j.scr.2024.103437. Epub 2024 May 4.

引用本文的文献

1
Gene-editing in patient and humanized-mice primary muscle stem cells rescues dysferlin expression in dysferlin-deficient muscular dystrophy.在患者和人源化小鼠的原代肌肉干细胞中进行基因编辑可挽救dysferlin缺乏型肌营养不良症中dysferlin的表达。
Nat Commun. 2025 Jan 2;16(1):120. doi: 10.1038/s41467-024-55086-0.
2
Cas9-induced single cut enables highly efficient and template-free repair of a muscular dystrophy causing founder mutation.Cas9诱导的单一切割能够高效且无模板地修复导致肌营养不良的奠基者突变。
Mol Ther Nucleic Acids. 2023 Feb 5;31:494-511. doi: 10.1016/j.omtn.2023.02.005. eCollection 2023 Mar 14.
3
Co-Regulated Gene Expression as a Suitable Readout after Precise Gene Correction.
精确基因校正后的共调控基因表达作为合适的读出结果。
Int J Mol Sci. 2022 Dec 8;23(24):15525. doi: 10.3390/ijms232415525.
4
Generation of hiPSC-Derived Skeletal Muscle Cells: Exploiting the Potential of Skeletal Muscle-Derived hiPSCs.人诱导多能干细胞衍生的骨骼肌细胞的生成:挖掘骨骼肌来源的人诱导多能干细胞的潜力。
Biomedicines. 2022 May 23;10(5):1204. doi: 10.3390/biomedicines10051204.